Sorbact dressings in hard-to-heal wounds

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an open, single-center, exploratory study to see if three Sorbact dressings can bind bacteria and fungi from hard-to-heal wounds over 14 days. Participants are adults with hard-to-heal wounds starting one of the Sorbact dressings, assigned to Compress, Gel Dressing, or Ribbon Gauze in groups of 10. The study includes three visits (screening/baseline and two follow-ups) at Sahlgrenska University Hospital in Sweden. Outcomes focus on the extent of microbial binding to the dressing surface under real-use conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Able to read and understand the Subject Information and Informed Consent Form and provide meaningful informed consent
2. Due to start using one of the following dressings: Sorbact® Compress, Sorbact® Gel Dressing and Sorbact® Ribbon Gauze
3. Age ≥18 years
4. Presence of hard-to-heal wound for ≥6 weeks with no significant wound area reduction for the last 4 weeks confirmed by investigator/study nurse

Exclusion Criteria:

1. Participating in another clinical investigation
2. Known allergy or sensitivity to any components of the allocated investigational device
3. Use of antimicrobial agent (e.g., silver- or iodine-containing dressings, or gels) during the last wo weeks
4. Use of a dressing from the Sorbact® range during the last two weeks
5. Subjects with any other condition that as judged by the investigator may make investigation procedures inappropriate

Where it's running

• Sahlgrenska University Hospital
  Mölndal, Sweden Recruiting

Study contacts

• Principal investigator: Anders Jönsson, MD — Sahlgrenska University Hospital
• Study coordinator: Fana Hunegnaw
• Email: fana.hunegnaw@essity.com
• Phone: +46761361512

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• THERAVEX Tissue Care Spray Plus for Healing of Skin Wounds and Ulcers

  This observational review tests whether THERAVEX Tissue Care Spray Plus, used with standard wound care, helps heal various skin wounds and chronic ulcers in adults.

  Recruiting Biointelligent Technology Systems SL · Barcelona · NCT07617961

• Human placental membrane products plus standard care for nonhealing diabetic foot and venous leg ulcers

  This trial will try human placental membrane products together with standard wound care to help adults whose diabetic foot ulcers or venous leg ulcers have not healed.

  Recruiting BioLab Holdings · Philidelphia, Pennsylvania · NCT07364630

• Using human placental membrane wraps with regular wound care to help heal stubborn diabetic foot and venous leg ulcers

  This trial tests whether adding one of four human placental membrane wraps to standard wound care helps people with nonhealing diabetic foot or venous leg ulcers heal faster and more completely than standard care alone.

  Recruiting Phase 4 BioLab Holdings · Philidelphia, Pennsylvania · NCT07089602

• Evaluating new treatments for nonhealing diabetic foot and venous leg ulcers.

  This study is testing whether new treatments for stubborn diabetic foot and leg ulcers can help people heal better when combined with standard care compared to just standard care alone.

  Recruiting Phase 4 Tiger Biosciences, LLC. · Monroeville, Pennsylvania · NCT06826339

• Evaluating new treatments for diabetic foot and venous leg ulcers

  This study is testing different new treatments for stubborn diabetic foot and leg ulcers to see if they help heal better than the standard care alone.

  Recruiting Stability Biologics · Circleville, Ohio · NCT06560502

• Comparing PelloGraft and SanoGraft for treating diabetic foot and venous leg ulcers

  This study is testing whether PelloGraft can help heal diabetic foot ulcers and SanoGraft can help heal venous leg ulcers better than standard care.

  Recruiting at 2 sites Surgenex · Vista, California and 1 other locations · NCT06515093

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.